65,437 trials
Congenital Bleeding Disorder · Haemophilia A With Inhibitors · Haemophilia B With Inhibitors
Primary: Percent Change in Total Bleed Episodes Per Month - Bleeding Population — -45 percent change (%) in bleeds per month
Wounds
Primary: Time to Complete Wound Closure (Epithelialization) — 10.9; 13.1; 16.3 days — p=0.0062
Asthma
Primary: Persistency of Response and Non-response as Based on Investigator's Global Evaluation of Treatment Effectiveness (GETE) — 190; 29; 187; 28 participants
Chronic Hepatitis B
Primary: Percentage of Participants Who Maintained Therapeutic Response [Group A: LdT Pool 2302/015] — 67.2; 73.8; 81.7; 86.3 Percentage of participants
Growth Hormone Deficiency
Primary: Subject-reported Injection Anxiety Immediately Before Administration — 2.15; 1.98 Scores on a scale
HIV Infections
Primary: Number of Severe (DAIDS Grades 3 or 4) Adverse Events Related to Drug for Treated Patients by Age Group and Formulation — 2; 6; 3; 2 participants
Bilateral Cataract
Primary: Number of Subjects Reporting Spatial Distortions Related to Intraocular Lens (IOL) Misalignment — 11; 2 Participants
Chronic Obstructive Pulmonary Disease
Primary: Oxygen Response — 26.9 Meter
Carcinoma of the Head and Neck
Primary: Completion Rate — 100 percentage of participants
Breast Neoplasms
Primary: Number of Participants With Objective Response — 7 Participants
Hypertension
Primary: Change in 24 Hour (24-Hr) Mean Ambulatory Systolic Blood Pressure (MASBP) From the End of the Active Treatment Period to Day 7 of the Withdrawal Period — 2.70; 6.51 mmHg
Acute Pain Following a Total Abdominal Hysterectomy
Primary: Average Pain Intensity at Rest Over Days 1 to 3 — 2.40; 2.46; 3.26 Score on a scale — p=<0.001
Prostatic Hyperplasia
Primary: Number of Participants With Clinical Progression — 176; 202; 266; 232 participants — p=<0.001
Blood Platelet Disorders
Primary: Response to Drug Based on Platelet Count at the End of Therapy — 91.6 percentage of participants
Atrial Fibrillation
Primary: Probability of Maintenance of Sinus Rhythm at One-year Follow up.(Number of Patients Who Maintained Sinus Rhythm) — 61; 34 partecipants — p=< 0.05